Clinical Trial Update: A First-Time-In-Human Study in Healthy Subjects [Phase 1]

View source ↗

Summary

GlaxoSmithKline's first-in-human Phase 1 study in healthy subjects for an obesity-related compound has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Snippet

Sponsor: GlaxoSmithKline | Conditions: Obesity | Phase 1 | Status: COMPLETED